{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:59:15Z","timestamp":1793228355400,"version":"4.5.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Swedish Heart and Lung Foundation"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Martin Rind\u2019s and Westman\u2019s Foundations"},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K08DK092287"],"award-info":[{"award-number":["K08DK092287"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"US National Kidney Foundation"},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1093\/ehjqcco\/qcy019","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T02:42:44Z","timestamp":1524710564000},"page":"267-273","source":"Crossref","is-referenced-by-count":32,"title":["A real-world cohort study on the quality of potassium and creatinine monitoring during initiation of mineralocorticoid receptor antagonists in patients with heart failure"],"prefix":"10.1093","volume":"4","author":[{"given":"Erik","family":"Nilsson","sequence":"first","affiliation":[{"name":"Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska Universitetssjukhuset Huddinge, Stockholm, Stockholm, Sweden"},{"name":"Department of Internal Medicine, School of Medical Sciences, \u00d6rebro University, S\u00f6dra Grev Rosengatan, \u00d6rebro, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"De Deco","sequence":"additional","affiliation":[{"name":"Milano Biccoca University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Trevisan","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics (MEB), Karolinska Institutet, Nobels v\u00e4g 12A, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Bellocco","sequence":"additional","affiliation":[{"name":"Milano Biccoca University, Milan, Italy"},{"name":"Department of Medical Epidemiology and Biostatistics (MEB), Karolinska Institutet, Nobels v\u00e4g 12A, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Lindholm","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska Universitetssjukhuset Huddinge, Stockholm, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H","family":"Lund","sequence":"additional","affiliation":[{"name":"Department of Medicine, Karolinska Institutet, Karolinska Universitetssjukhuset, Solna, Stockholm, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, W6508, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J","family":"Carrero","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics (MEB), Karolinska Institutet, Nobels v\u00e4g 12A, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"key\n\t\t\t\t20181008053243308_qcy019-B1","first-page":"1167.","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"69","author":"Ponikowski","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B2","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology foundation\/American Heart Association task force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B5","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacc.2005.06.010","article-title":"The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure","volume":"46","author":"Shah","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1345\/aph.1H520","article-title":"Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia?","volume":"41","author":"Raebel","year":"2007","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B8","first-page":"43","article-title":"Guideline concordance of testing for hyperkalemia and kidney dysfunction during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure","volume":"7","author":"Allen","year":"2014","journal-title":"Circulation: Heart Fail"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B9","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1001\/jama.2015.11904","article-title":"Consistency of laboratory monitoring during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure","volume":"314","author":"Cooper","year":"2015","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ahj.2015.06.006","article-title":"Facility variation and predictors of serum potassium monitoring after initiation of a mineralocorticoid receptor antagonist in patients with heart failure","volume":"170","author":"Chauhan","year":"2015","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B11","doi-asserted-by":"crossref","first-page":"e002946.","DOI":"10.1161\/CIRCOUTCOMES.116.002946","article-title":"Characterization of mineralocorticoid receptor antagonist therapy initiation in high-risk patients with heart failure","volume":"10","author":"Cooper","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ckj\/sfv117","article-title":"The Stockholm CREAtinine Measurements (scream) project: protocol overview and regional representativeness","volume":"9","author":"Runesson","year":"2016","journal-title":"Clin Kidney J"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/HYPERTENSIONAHA.116.07363","article-title":"Antihypertensive medications and the prevalence of hyperkalemia in a large health system","volume":"67","author":"Chang","year":"2016","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2017.07.035","article-title":"Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system","volume":"245","author":"Nilsson","year":"2017","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ejhf.496","article-title":"Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012","volume":"18","author":"Thorvaldsen","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B17","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ejhf.781","article-title":"Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry","volume":"19","author":"Lund","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the randomized aldactone evaluation study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B19","doi-asserted-by":"crossref","first-page":"c1768.","DOI":"10.1136\/bmj.c1768","article-title":"Spironolactone use and renal toxicity: population based longitudinal analysis","volume":"340","author":"Wei","year":"2010","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B20","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.jacc.2010.07.013","article-title":"Heart failure guidelines, performance measures, and the practice of medicine: mind the gap","volume":"56","author":"Ghali","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B21","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1093\/eurheartj\/ehs257","article-title":"Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice","volume":"33","author":"Zannad","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0897190009358770","article-title":"Adherence to amiodarone monitoring recommendations before and after implementation of a centralized pharmacy service: a cohort study","volume":"23","author":"Johnson","year":"2010","journal-title":"J Pharm Pract"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B23","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1001\/archinte.165.20.2395","article-title":"Improving laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial","volume":"165","author":"Raebel","year":"2005","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archinte.163.8.893","article-title":"Linking laboratory and pharmacy: opportunities for reducing errors and improving care","volume":"163","author":"Schiff","year":"2003","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B25","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.clinthera.2009.06.014","article-title":"Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review","volume":"31","author":"Snider","year":"2009","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0272989X10379918","article-title":"An economic evaluation of a laboratory monitoring program for renin-angiotensin system agents","volume":"31","author":"Smith","year":"2011","journal-title":"Med Decis Making"},{"key":"key\n\t\t\t\t20181008053243308_qcy019-B27","first-page":"281","article-title":"Improving laboratory monitoring of medications: an economic analysis alongside a clinical trial","volume":"15","author":"Smith","year":"2009","journal-title":"Am J Manag Care"}],"container-title":["European Heart Journal - Quality of Care and Clinical Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjqcco\/article-pdf\/4\/4\/267\/25948159\/qcy019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T22:58:48Z","timestamp":1571266728000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article\/4\/4\/267\/4991606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,5,2]]},"published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjqcco\/qcy019","relation":{},"ISSN":["2058-5225","2058-1742"],"issn-type":[{"value":"2058-5225","type":"print"},{"value":"2058-1742","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,10]]},"published":{"date-parts":[[2018,5,2]]}}}